Brain stimulation plus counseling for cannabis use
This study tests whether adding a noninvasive brain stimulation technique (called tACS) to motivational interviewing—a type of counseling—can help people reduce their cannabis use. You will receive the brain stimulation during counseling sessions, and your progress will be monitored over several weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You consider your cannabis use to be a problem.
- You have not been in treatment for another substance (like alcohol or opioids) in the past 30 days.
- You have no history of brain injury, major neurological disease, or vascular/neurodegenerative disorder.
- You do not have current psychosis or a past-year substance use disorder other than cannabis, alcohol, or nicotine.
- You are not pregnant or have no other reason you cannot undergo MRI or brain stimulation (tACS).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a gentle brain stimulation technique (called tDCS) can help people who want to cut down or stop using cannabis. You'll wear a headband-like device during sessions at NYU, and the study team will check in with you over time.
This trial tests whether a treatment called repetitive transcranial magnetic stimulation (a non-surgical magnetic stimulation to the brain) can help people reduce or stop cannabis use. You may be eligible if you have cannabis use disorder and meet specific safety and symptom criteria.
This study tests whether transcranial magnetic stimulation (TMS)—a non-invasive technique that uses magnetic pulses to stimulate the brain—can help reduce cannabis use in people ages 15–21. TMS is already used to treat depression and may help reduce cravings and urges to use cannabis.
This trial studies whether a noninvasive brain stimulation method (tDCS) can reduce cannabis cravings in people with schizophrenia who use cannabis often. It may help by lowering craving and improving control over cannabis use, but you must meet specific safety and medication-use requirements.
This study tests if psilocybin (a substance that can change how you think and feel) can help people reduce or stop using cannabis. You will receive support and be monitored closely throughout the trial.
This study tests whether a non-invasive brain stimulation device can make standard psychotherapy work better for people who drink in a risky way. It’s designed for community participants who are not already in alcohol-use treatment.
Hear when a new Cannabis Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.